FindTrial
Sign In

Saccharomyces Boulardii 250 MG

DRUG5 trials

Sponsors

Tatyasaheb Kore Dental College, Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno, The Third Xiangya Hospital of Central South University, Fakultas Kedokteran Universitas Indonesia, Biocodex

Conditions

Chronic PeriodontitisHelicobacter Pylori InfectionIBS (Irritable Bowel Syndrome)IBS, Mixed SymptomsIBS-D (Diarrhea-predominant)Irritable Bowel Syndrome

Phase 1

Effect Of A Locally Delivered Probiotic Sacchraomyces Boulardii In The Management Of Chronic Periodontitis
CompletedNCT03516370
Tatyasaheb Kore Dental CollegeChronic Periodontitis
Start: 2017-11-20End: 2018-03-26Updated: 2018-05-11

Phase 3

Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome
RecruitingNCT07168434
BiocodexIBS-D (Diarrhea-predominant), IBS (Irritable Bowel Syndrome), IBS, Mixed Symptoms
Start: 2025-10-22End: 2026-10-11Target: 406Updated: 2025-11-18

Phase 4

Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth
CompletedNCT04627337
Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoIrritable Bowel Syndrome
Start: 2017-02-01End: 2018-08-31Updated: 2020-11-13

Unknown Phase

Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter Pylori
CompletedNCT05191875
The Third Xiangya Hospital of Central South UniversityHelicobacter Pylori Infection
Start: 2021-12-01End: 2022-04-23Updated: 2022-05-24
The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS
NCT05451433
Fakultas Kedokteran Universitas IndonesiaIrritable Bowel Syndrome
Start: 2022-08-01End: 2022-12-01Target: 52Updated: 2022-07-20